Single genome sequencing of near full-length HIV-1 RNA using a limiting dilution approach

J Virol Methods. 2019 Dec:274:113737. doi: 10.1016/j.jviromet.2019.113737. Epub 2019 Sep 25.

Abstract

Sequencing very long stretches of the HIV-1 genome can advance studies on virus evolution and in vivo recombination but remains technically challenging. We developed an efficient procedure to sequence near full-length HIV-1 RNA using a two-amplicon approach. The whole genome was successfully amplified for 107 (88%) of 121 plasma samples including samples from patients infected with HIV-1 subtype A1, B, C, D, F1, G, H, CRF01_AE and CRF02_AG. For the 17 samples with a viral load below 1000 c/ml and the 104 samples with a viral load above 1000 c/ml, the amplification efficiency was respectively 53% and 94%. The sensitivity of the method was further evaluated using limiting dilution of RNA extracted from a plasma pool containing an equimolar mixture of three HIV-1 subtypes (B, C and CRF02_AG) and diluted before and after cDNA generation. Both RNA and cDNA dilution showed comparable sensitivity and equal accuracy in reflecting the subtype distribution of the plasma pool. One single event of in vitro recombination was detected amongst the 41 sequences obtained after cDNA dilution but no indications for in vitro recombination were found after RNA dilution. In conclusion, a two-amplicon strategy and limiting dilution of viral RNA followed by reverse transcription, nested PCR and Sanger sequencing, allows near full genome sequencing of individual HIV-1 RNA molecules. This method will be a valuable tool in the study of virus evolution and recombination.

Keywords: HIV-1 RNA limiting dilution; Near full-length HIV-1 sequencing; Recombination; Single genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Complementary / genetics
  • Genotype
  • HIV Infections / virology
  • HIV-1 / genetics*
  • Humans
  • Plasma / virology
  • Polymerase Chain Reaction
  • RNA, Viral / genetics*
  • Sensitivity and Specificity
  • Whole Genome Sequencing / methods*

Substances

  • DNA, Complementary
  • RNA, Viral